Bristol Myers Squibb
The Director, Clinical Genomics & Molecular Assay Development provides strategic leadership for clinical genomics, transcriptomics, and molecular biomarker assay activities supporting translational medicine and clinical development programs. This functional leader partners with cross-functional teams and external partners to define assay strategies, manage validation, and deliver high-quality genomic data. The role requires direct oversight of lab scientists, hands-on experimental work, and driving innovation in emerging genomics technologies.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
52% above the average for this role
Specialist Scientist / Lead Scientist
Syngene International Limited
Director, Molecular Genetics
MPI
Postdoctoral Research Associate – Ocular Cellular, Molecular, and Genomics Research
PeopleAdmin
Scientist II
Dana-Farber Cancer Institute
Principal Scientist
Syngene International Limited
Senior Scientist, Analytical Genomics
Novartis